Abstract

This Themed Section of Value in Health focuses on the intricate health economics of Alzheimer’s disease and related dementias (ADRD). As the aging population grows and novel diagnostic and treatment options emerge, understanding the complex economic implications of ADRD becomes increasingly critical. Conventional methods are often limited in capturing the full spectrum of costs and health impacts of ADRD, necessitating the adoption of new frameworks, broader considerations of economic outcomes, and an unwavering focus on health equity. The collection of articles in this Themed Section provides insights into these critical areas, providing a roadmap for future research and policy.